These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Somatostatin analogs: status of the art and perspectives in the treatment of endocrine and non endocrine diseases. Proceedings of a conference. May 30-31, 2003. Naples, Italy. J Endocrinol Invest; 2003; 26(8 Suppl):1-135. PubMed ID: 15307251 [No Abstract] [Full Text] [Related]
3. Primary therapy for acromegaly with somatostatin analogs and a discussion of novel peptide analogs. Kleinberg DL Rev Endocr Metab Disord; 2005 Jan; 6(1):29-37. PubMed ID: 15711912 [No Abstract] [Full Text] [Related]
5. The role of somatostatin analogs in the control of tumor growth. Lamberts SW; Reubi JC; Krenning EP Semin Oncol; 1994 Oct; 21(5 Suppl 13):61-4. PubMed ID: 7992085 [No Abstract] [Full Text] [Related]
6. Somatostatin analogs for the treatment of neuroendocrine tumors. Culler MD; Oberg K; Arnold R; Krenning EP; Sevilla I; Díaz JA Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():9-17. PubMed ID: 21369878 [TBL] [Abstract][Full Text] [Related]
7. [International symposium on somatostatin analogues: fundamental aspects and clinical perspectives. Venice, Italy, 24-25 October 1997. Abstracts]. Ann Endocrinol (Paris); 1998; 59 Suppl 2():1-52. PubMed ID: 10065269 [No Abstract] [Full Text] [Related]
8. Clinical use of somatostatin analogues (Sandostatin, SMS 20l-995). Proceedings of a symposium. Amsterdam, November 14, 1986. Acta Endocrinol Suppl (Copenh); 1987; 286():1-66. PubMed ID: 2892333 [No Abstract] [Full Text] [Related]
9. [Somatostatin analogs in the treatment of carcinoid syndrome: a case report and review of literature]. Junik R; Kamińska A; Kamiński M; Ruprecht Z Pol Arch Med Wewn; 2003 Sep; 110(3):997-1001. PubMed ID: 14699693 [TBL] [Abstract][Full Text] [Related]
10. [The use of somatostatin analogs in the treatment of patients with digestive system diseases]. Frol'kis AV Ter Arkh; 1999; 71(2):83-5. PubMed ID: 10222565 [No Abstract] [Full Text] [Related]
11. [Medical treatment of acromegaly. Somatostatin analogs offer a real hope]. Kuhn JM; Héron I Rev Prat; 1992 Nov; 42(18):2303-7. PubMed ID: 1363585 [No Abstract] [Full Text] [Related]
12. Depot somatostatin analogs--a new first line therapy for acromegaly. Robbins RJ J Clin Endocrinol Metab; 1997 Jan; 82(1):15-7. PubMed ID: 8989224 [No Abstract] [Full Text] [Related]
13. Somatostatin analogues in the treatment of the carcinoid syndrome. Deghenghi R Biomed Pharmacother; 1988; 42(9):585-8. PubMed ID: 2907298 [TBL] [Abstract][Full Text] [Related]
14. Currently available somatostatin analogs are not good for Graves' orbitopathy. Tanda ML; Bartalena L J Endocrinol Invest; 2006 May; 29(5):389-90. PubMed ID: 16794359 [No Abstract] [Full Text] [Related]
15. [Biological activities of somatostatin analogs (author's transl)]. Kokubu T; Sawano S Horumon To Rinsho; 1979 May; 27(5):473-82. PubMed ID: 378472 [No Abstract] [Full Text] [Related]
16. Somatostatin Analog Therapy in Small Cell Lung Cancer. Tartarone A; Lerose R; Aieta M Semin Nucl Med; 2016 May; 46(3):239-42. PubMed ID: 27067504 [TBL] [Abstract][Full Text] [Related]